Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

usd-jpy
Julian Parker 2026 Jun 23, 16:01

USD/JPY Forecast: Analyzing the 161.60 Threshold Amid BoJ Policy Friction and Intervention Risks

forex
Julian Parker 2026 Jun 21, 16:03

Crude Oil Price Forecast 2026–2030: Macro Fundamentals, Geopolitics, and Trading Strategies

commodity
Julian Parker 2026 Jun 17, 16:02

FOMC June 2026: Warsh’s Hawkish Pivot and Forex Market Impact

forex
Julian Parker 2026 Jun 17, 16:01

SpaceX Stock Forecast 2027, 2031 and 2036: What the Lockup Schedule Means for SPCX Shares

stocks
Julian Parker 2026 Jun 16, 16:03

USD/CAD Forecast: Oil Weakness Keeps 1.4000 in Focus

forex
Julian Parker 2026 Jun 16, 16:01

Bitcoin and the Fed’s Guidance Shift: Short-Term Risk, Long-Term Narrative

crypto
Julian Parker 2026 Jun 16, 16:01

Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%

indices
Julian Parker 2026 Jun 14, 16:05

5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath

cfd trading stocks
Julian Parker 2026 Jun 14, 16:02

How to Trade the SpaceX (SPCX) IPO Surge From South Africa With CFDs — Without Owning a Single Share

stocks
Julian Parker 2026 Jun 10, 16:01

SpaceX IPO Puts S&P 500 Inclusion Question in Focus

stocks

Latest news

Show more
micron
Julian Parker 2026 Jun 23, 16:05

Kospi's $474 Billion Rout Exposes AI Concentration Risks Ahead of Micron Report

stocks
gold-produce
Julian Parker 2026 Jun 23, 16:03

Gold Approaches Critical $4,000 Threshold as Hawkish Fed Repricing Eclipses Geopolitical Premium

gold price today
wti-oil
Julian Parker 2026 Jun 23, 16:02

WTI Crude Edges Higher but Remains Under Pressure Near $72.50 After Recent Low

Commodities
nasdaq
Julian Parker 2026 Jun 23, 16:01

Nasdaq Drops 2.21%, Micron Plunges 13% as Semiconductor Stocks Tumble

Stock
Julian Parker 2026 Jun 22, 16:05

South Korean Chip Stocks Slide as Profit-Taking Hits Samsung and SK Hynix

Stock
Julian Parker 2026 Jun 22, 16:05

SpaceX Stock Falls 16% as Post-IPO Rally Loses Momentum

Stock
Julian Parker 2026 Jun 22, 16:04

Dow Advances on Value Rotation While Tech Sell-Off and Plunging Crude Drag S&P 500, Nasdaq Lower

stocks
Julian Parker 2026 Jun 22, 16:02

Gold Price Today, June 23: Spot Gold Nears $4,200 as US-Iran Peace Roadmap Curbs Inflation Fears

gold price today

Info

Spread

0.35

Spread (%)

0.6352 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

113396219904

Shares Outstanding

2042071247

Earnings Date (Next)

2001-08-07

Div Yield

2026-08-03

Ex-Dividend Date

2026-07-02

Forward annual dividend rate

2.52

Forward annual dividend yield

0.0461

EPS

3.63

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies. Bristol-Myers Squibb Company has a strategic collaboration with Arcus Biosciences, Inc. to develop a novel treatment regimen that delivers tumor control in kidney cancer. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Jun 23, 16:05

11 Best Swap-Free Account CFD Brokers in Dubai 2026

Swap-Free Account
Julian Parker 2026 Jun 23, 16:04

11 Best Swap-free Account CFD Brokers in 2026

Julian Parker 2026 Jun 22, 16:05

Do You Have to Be Muslim for a Swap-Free Account?

Trustpilot